πŸ‡ΊπŸ‡Έ FDA
Patent

US 10065952

Valbenazine salts and polymorphs thereof

granted A61PA61P25/00A61P25/14

Quick answer

US patent 10065952 (Valbenazine salts and polymorphs thereof) held by Neurocrine Biosciences, Inc. expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P25/00, A61P25/14